‘Freedom from Cancer’ project helps 200 patients with treatment and care

The 'Freedom from Cancer' project provides free treatment for 200 blood cancer patients, ensuring long-term remission and ...
American College of Cardiology

New Study Finds Chronic High Caffeine Consumption May Heighten Risk for Cardiovascular Disease

From coffee to tea, caffeinated beverages are an integral part of morning routines across the globe, but these popular drinks can be harmful when enjoyed in excess. According to a new study being ...

Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participan ...
TMCnet

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity

The FALCON Phase 2 trial is a U.S.-based, multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of TERN-601, a novel oral GLP-1R agonist, with once-daily ...